OpenAI: New capabilities for GPT-Rosalind, a model for the life sciences
On 3 June 2026, OpenAI introduced new capabilities for GPT-Rosalind, a model focused on research in the life sciences. The announced improvements include enhanced biological reasoning, expertise in medicinal chemistry, genomics analysis and support for experimental workflows.